STOCKWATCH
·
Medical/Dental Instruments
Quarterly ResultMay 7, 2026, 04:07 PM

Nephros Q1 Net Income $140K, Down 75%; Revenue Up 6.9% to $5.2M

AI Summary

Nephros Inc. reported a significant decrease in net income for the first quarter of 2026, falling 75% to $140,000, or $0.01 per basic share, despite a 6.9% increase in total net revenues to $5.2 million. The company also shifted from generating cash to using $1.67 million in operating activities, primarily due to increases in inventory and accounts receivable. Post-quarter, Nephros applied for a $646,698 refund for previously paid IEEPA tariffs.

Key Highlights

  • Net income for Q1 2026 decreased 74.9% to $140,000 from $558,000 in Q1 2025.
  • Total net revenues increased 6.9% to $5.21 million in Q1 2026 from $4.88 million in Q1 2025.
  • Basic net income per common share fell to $0.01 in Q1 2026 from $0.05 in Q1 2025.
  • Gross margin decreased 5.1% to $2.99 million in Q1 2026 from $3.15 million in Q1 2025.
  • Net cash used in operating activities was $1.67 million in Q1 2026, compared to $322,000 provided in Q1 2025.
  • Cash and cash equivalents decreased to $4.02 million as of March 31, 2026, from $5.40 million at December 31, 2025.
  • Accounts receivable increased by $1.11 million to $3.52 million from December 31, 2025.
  • Applied for a $646,698 refund for IEEPA tariffs in April 2026.
NEPH
Medical/Dental Instruments
NEPHROS INC

Price Impact